Developing Analytical Control Strategies for Therapeutic Oligonucleotides

Time: 3:00 pm
day: Day Two

Details:

  • Outlining the analytical challenges in developing therapeutic oligonucleotides
  • Discussing how to identify and meet these challenges
  • Establishing the importance of platform knowledge and how an analytical control strategy can be developed during clinical development

REMOTE PRESENTATION

Speakers: